Arthur Greyf DDS FICOI is Osseoprint 3D’s CEO and Chief Medical Officer. Arthur is a renowned implantologist who has dedicated most of his career to streamlining the implant process and improving patient outcomes. Dr. Greyf developed much of OsseoPrint 3D’s medical IP and is widely sought by patients from around the world. Dr. Greyf is also a former clinical professor at SUNY Downstate.

Dawn Norman is head of regulatory affairs at OP3D. She possesses 18 years of experience in regulatory affairs, quality systems and clinical affairs in the medical device industry. She has expertise is in Class I, II and III devices, combination products and tissues such as recombinant proteins for bone fusion, orthopedic trauma, software, imaging technologies, vascular access and dental technologies.  

Marina Kolesnik is an experienced executive, entrepreneur and startup fundraiser. Most recently she built a successful company in Russia and raised over $30 million to date. Prior to that she was a CFO of Mail.ru and began her career as a consultant with McKinsey & Co. in their healthcare practice.

Dr. Kohn is Professor Emeritus in the Chemistry and Chemical Biology Department at the School of Arts and Sciences, Rutgers University and former director of the New Jersey Center of Biomaterials.

He specializes in biocompatible polymers and holds over 70 US patents. He is a three-time recipient of the Edison Award for the best medical technology patent in New Jersey.